Acadia: Q4 Earnings Snapshot

SAN DIEGO (AP) — SAN DIEGO (AP) — Acadia Pharmaceuticals Inc. (ACAD) on Monday reported a loss of $41.7 million in its fourth quarter.

On a per-share basis, the San Diego-based company said it had a loss of 26 cents.

The results did not meet Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.

The drugmaker posted revenue of $136.5 million in the period, topping Street forecasts. Nine analysts surveyed by Zacks expected $134.4 million.

For the year, the company reported that its loss widened to $216 million, or $1.34 per share. Revenue was reported as $517.2 million.

Acadia shares have risen 22% since the beginning of the year. In the final minutes of trading on Monday, shares hit $19.40, a fall of 24% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ACAD at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up